Pfizer Inc.

NYSE:PFE   3:59:59 PM EDT
37.98
-0.20 (-0.52%)
4:05:27 PM EDT: $37.95 -0.03 (-0.08%)
Products

Biontech And Pfizer Initiate Rolling Submission To European Medicines Agency

Published: 10/06/2020 09:13 GMT
Pfizer Inc (PFE) - Biontech Se - Biontech and Pfizer Initiate Rolling Submission to European Medicines Agency for Sars-cov-2 Vaccine Candidate Bnt162b2.
Biontech Se - Vaccine Candidate is Currently Being Evaluated in a Global Phase 3 Study Ongoing at More Than 120 Clinical Sites Worldwide Including United States, Brazil, South Africa and Argentina.
Biontech Se - Trial Has Enrolled Approximately 37,000 Participants With More Than 28,000 Having Received Their Second Vaccinatio.